Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 9, 2022 - Issue
Submit an article Journal homepage
79
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study

Bowen Chen1 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of China;2 Peking University 302 Clinical Medical School, Beijing, People’s Republic of ChinaView further author information
,
Jin Lei1 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of China;3 Guizhou Medical University Clinical Medical School, Guiyang, People’s Republic of ChinaView further author information
,
Haitao Zhao4 Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of ChinaView further author information
,
Jinghui Dong5 Radiology Department, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
,
Zhen Zeng1 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
,
Yinyin Li1 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
,
Lingxiang Yu1 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
,
Lin Zhou6 Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
,
Aiying Jia5 Radiology Department, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
,
Yinying Lu1 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of China;2 Peking University 302 Clinical Medical School, Beijing, People’s Republic of China;3 Guizhou Medical University Clinical Medical School, Guiyang, People’s Republic of ChinaView further author information
&
Jiamin Cheng1 Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-5238-6027View further author information
ORCID Icon show all
Pages 1171-1185 | Received 31 Aug 2022, Accepted 13 Oct 2022, Published online: 08 Nov 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xuezhu Wang, Xu Yang, Jingnan Wang, Chengyan Dong, Jie Ding, Meiqi Wu, Yanyu Wang, Haiyan Ding, Hui Zhang, Xinting Sang, Haitao Zhao & Li Huo. (2023) Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents. Journal of Hepatocellular Carcinoma 10, pages 587-598.
Read now

Articles from other publishers (1)

Takayuki Kondo, Kisako Fujiwara, Miyuki Nakagawa, Kentaro Fujimoto, Sae Yumita, Takamasa Ishino, Keita Ogawa, Terunao Iwanaga, Keisuke Koroki, Hiroaki Kanzaki, Masanori Inoue, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Sadahisa Ogasawara, Shingo Nakamoto, Tetsuhiro Chiba, Jun Kato & Naoya Kato. (2023) Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients. Scientific Reports 13:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.